Viracta Therapeutics
VIRX
#10159
Rank
HK$54.01 M
Marketcap
HK$1.36
Share price
-6.13%
Change (1 day)
-67.81%
Change (1 year)

Viracta Therapeutics (VIRX) - Cash on Hand

Cash on Hand as of September 2024 : HK$0.16 Billion

According to Viracta Therapeutics's latest financial reports the company has HK$0.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viracta Therapeutics - Cash on Hand chart (from 2020 to 2024)

2021202220232024$0.2B$0.4B$0.6B$0.8B$1B$1.2Bcompaniesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$0.41 B-41.05%
2022-12-31HK$0.71 B-11.9%
2021-12-31HK$0.80 B121.2%
2020-12-31HK$0.36 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$2.12 B 1,188.89%๐Ÿ‡บ๐Ÿ‡ธ USA